News & Events about Thermo Fisher Scientific Inc.
Data readout for TREK-AD Phase 2b study of eblasakimab on track for early July 2023Four abstracts on eblasakimab and farudodstat, including two late-breakers, to be presented at the 1st International Societies of Investigative Dermatology meeting May 10-13 in Tokyo$20 million private placement led ...
Goldstein Advisors LLC acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 730 shares of the medical research companys stock, valued at ...
Cedar Brook Financial Partners LLC reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 2.6% in the 4th quarter, according to the company in its most recent filing with the Securities Exchange Commission. The fund owned 702 shares of the medical ...
Business Wire
2 months ago
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2023 Investor Day on Wednesday, May 24, starting at 9:00 a.m. (ET)in New York City. The format will feature presentations by members of Thermo Fisher Scientifics senior management team...
First American Trust FSB lifted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO Get Rating) by 24.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,447 shares of the...